Carol A. Baum

Keine laufenden Positionen mehr

65 Jahre

Health Technology

Consumer Services

Profil

Carol A.
Baum worked as a Marketing Director at Aventis Pharmaceuticals, Inc. She then worked as Vice President-Marketing at Neurocrine Biosciences, Inc. from 2003 to 2008.
After that, she worked as Vice President-Commercialization at Orexigen Therapeutics, Inc. Ms. Baum received an undergraduate degree from The University of Colorado and an MBA from Webster University.

Ehemalige bekannte Positionen von Carol A. Baum

Unternehmen	Position	Ende
NEUROCRINE BIOSCIENCES, INC.	Vertrieb & Marketing	01.02.2008
OREXIGEN THERAPEUTICS, INC.	Corporate Officer/Principal	-
Aventis Pharmaceuticals, Inc. Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.	Vertrieb & Marketing	-

Sehen Sie sich die Erfahrung von Carol A. Baum im Detail an

Ausbildung von Carol A. Baum

The University of Colorado	Undergraduate Degree
Webster University	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Carol A. Baum im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
NEUROCRINE BIOSCIENCES, INC.	Health Technology

Private Unternehmen	2
Aventis Pharmaceuticals, Inc. Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.	Health Technology
Orexigen Therapeutics, Inc. Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.	Health Technology